Microscopy & Microtechniques
Low dose carbon monoxide therapy found to prevent miscarriage
Feb 20 2012
New research has found that low dose carbon monoxide therapy is able to restore placental functional and prevent miscarriages in mice, without any detrimental effects.
The study, conducted by researchers at the Otto-von-Guericke University, Germany and recently published in BioMed Central's open access journal Medical Gas Research, progressed on established research on Heme oxygenase-1, which is essential for the growth of blood vessels in the placenta and in establishing blood flow in the umbilical cord.
Both miscarriage and pre-eclampsia are associated with low levels of HO-1 in the placenta, however research suggests that carbon monoxide can mimic the effects of HO-1. The researchers found that an extended course of low dose (50ppm) carbon monoxide was able to reduce fetal loss from 30 per cent to zero, with all the babies surviving.
Prof Ana Claudia Zenclussen, who led the research explained: "At the levels used to prevent fetal death we found that inhaled low dose carbon monoxide was anti-inflammatory. It reduced the amount of cell death (apoptosis), and increased levels of the anti-apoptotic molecule BAG-1, in the placenta and additionally increased the level of vascular endothelial growth factor (VEGF), which is associated with angiogenesis and blood vessel repair."
Published by Neil Clark
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 03 2024 Gandhinagar, India
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA